Published in BMJ on March 20, 1993
Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol (1998) 5.29
Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. J Clin Pathol (1995) 1.19
Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities. BMJ (1995) 1.16
Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer (2000) 1.06
Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer (1996) 0.98
Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health (2009) 0.97
Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol (2011) 0.95
Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking. Br J Cancer (1994) 0.80
Smoking and human papillomavirus infection. Causal link not proved. BMJ (1993) 0.79
Smoking and human papillomavirus infection. Disease progression unrelated to smoking. BMJ (1993) 0.75
Epidemiological Investigation and Risk Factors for Cervical Lesions: Cervical Cancer Screening Among Women in Rural Areas of Henan Province China. Med Sci Monit (2016) 0.75
Smoking and human papillomavirus infection. Cervical epithelium vulnerable in smokers. BMJ (1993) 0.75
Efficacy trial of topically administered interferon gamma-1 beta gel in comparison to laser treatment in cervical intraepithelial neoplasia. Arch Gynecol Obstet (1995) 0.75
Association of oncogenic human papillomavirus DNA with high grade cervical intraepithelial neoplasia: the role of cigarette smoking. Sex Transm Infect (1999) 0.75
Cigarette smoking and cervical cancer. BMJ (1993) 0.75
A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res (1973) 5.13
Heterogeneity of the human papillomavirus group. J Virol (1989) 4.90
Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet (1986) 4.55
General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer (1990) 2.69
Cervical intraepithelial neoplasia. Pathol Annu (1973) 2.41
Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and southern-blot analysis. J Med Virol (1989) 2.28
Smoking and cervical cancer--current status: a review. Am J Epidemiol (1990) 2.11
Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. JAMA (1983) 2.03
A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol (1990) 1.98
Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet (1988) 1.66
Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med (1985) 1.62
Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol (1989) 1.53
Smoking as a risk factor in cancer of the cervix: additional evidence from a case-control study. Am J Epidemiol (1982) 1.53
Smoking and carcinoma in situ of the uterine cervix. Am J Public Health (1983) 1.24
Papillomavirus in anogenital cancer: the dilemma of epidemiologic approaches. J Natl Cancer Inst (1989) 1.22
PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer. Int J Cancer (1991) 1.01
Localization of human papillomavirus type 16 DNA using the polymerase chain reaction in the cervix uteri of women with cervical intraepithelial neoplasia. J Gen Virol (1989) 1.01
Mutagenic mucus in the cervix of smokers. J Natl Cancer Inst (1986) 1.00
Cigarette smoking and invasive cervical cancer. JAMA (1986) 1.00
Concept of the existence of human papillomavirus (HPV) DNA in histologically normal squamous epithelium of the genital tract should be re-evaluated. Acta Obstet Gynecol Scand (1989) 0.87
Human papilloma viruses and cervical intraepithelial neoplasia: the role of colposcopy. Gynecol Oncol (1987) 0.86
Topographic study of cervical condyloma and intraepithelial neoplasia. Cancer (1987) 0.85
Comparison of phage typing and DNA fingerprinting by polymerase chain reaction for discrimination of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol (1993) 3.40
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study. J Clin Microbiol (1991) 3.27
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol (1992) 3.05
Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol (1996) 2.94
Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1990) 2.86
Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting. J Clin Microbiol (1993) 2.79
Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol (1998) 2.77
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Rapid, polymerase chain reaction-based identification assays for Candida species. J Clin Microbiol (1993) 2.70
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol (1995) 2.66
Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet (1999) 2.27
Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction. J Virol Methods (1992) 2.25
Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1991) 2.21
Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp Infect (1993) 2.12
Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol (2000) 1.97
Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J Med Virol (1989) 1.95
Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology (2001) 1.84
Rapid and sensitive detection of Campylobacter spp. in chicken products by using the polymerase chain reaction. Appl Environ Microbiol (1992) 1.77
Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med (1994) 1.73
Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J Clin Microbiol (1989) 1.72
Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol (1987) 1.71
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Development of species-specific DNA probes for Campylobacter jejuni, Campylobacter coli, and Campylobacter lari by polymerase chain reaction fingerprinting. J Clin Microbiol (1993) 1.67
Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation (1987) 1.65
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother (2001) 1.60
Genotyping Naegleria spp. and Naegleria fowleri isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1992) 1.58
Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol (1989) 1.53
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1993) 1.49
Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1993) 1.47
Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol (1999) 1.43
Sensitivity of in situ detection with biotinylated probes of human papilloma virus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol (1988) 1.43
Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium. Hum Pathol (2002) 1.39
[The detection of melanoma metastases in sentinel nodes by polymerase chain reaction]. Ned Tijdschr Geneeskd (1998) 1.39
Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut (2002) 1.38
Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology (1997) 1.33
Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori. Gene (2000) 1.33
Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother (1999) 1.30
Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol (2001) 1.30
Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands. J Clin Microbiol (1994) 1.30
Molecular detection and genotyping of human papillomavirus. Expert Rev Mol Diagn (2001) 1.29
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer (2012) 1.28
'Candidatus Helicobacter suis', a gastric helicobacter from pigs, and its phylogenetic relatedness to other gastrospirilla. Int J Syst Bacteriol (1999) 1.28
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res (2001) 1.28
Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer (1999) 1.27
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut (2000) 1.24
Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol (1999) 1.23
Investigation of an outbreak of Campylobacter upsaliensis in day care centers in Brussels: analysis of relationships among isolates by phenotypic and genotypic typing methods. J Infect Dis (1995) 1.21
MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer (2007) 1.19
Campylobacter hyoilei Alderton et al. 1995 and Campylobacter coli Véron and Chatelain 1973 are subjective synonyms. Int J Syst Bacteriol (1997) 1.19
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. Cancer Res (1991) 1.16
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol (2009) 1.16
Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities. BMJ (1995) 1.16
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. Br J Cancer (2008) 1.15
Influence of volume of sample processed on detection of Chlamydia trachomatis in urogenital samples by PCR. J Clin Microbiol (1995) 1.15
Identification of human papillomavirus seroconversions. J Gen Virol (1995) 1.14
Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol (2001) 1.14
Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology (1997) 1.14
The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer (2004) 1.14
Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol (2001) 1.14
Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology (2001) 1.13
Molecular discrimination between Campylobacter jejuni, Campylobacter coli, Campylobacter lari and Campylobacter upsaliensis by polymerase chain reaction based on a novel putative GTPase gene. Mol Cell Probes (1997) 1.13
Prevalence of human papillomavirus infections among heterosexual men and women with multiple sexual partners. J Med Virol (1992) 1.12
A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet (2001) 1.11
The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol (1995) 1.11
Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology (1998) 1.11
Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol (1996) 1.10
Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. J Clin Oncol (1995) 1.10
Polyphasic analysis of strains of the genus Capnocytophaga and Centers for Disease Control group DF-3. Int J Syst Bacteriol (1996) 1.10
The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy. Cancer Res (2001) 1.08
Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Crit Rev Oncol Hematol (2003) 1.08
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study. Gynecol Oncol (2005) 1.08
Optimization of human papillomavirus genotype detection in cervical scrapes by a modified filter in situ hybridization test. J Clin Microbiol (1989) 1.07
Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J Cancer (1999) 1.06
Polymerase chain reaction-mediated DNA fingerprinting for epidemiological studies on Campylobacter spp. J Med Microbiol (1994) 1.05
Detection of the human papilloma virus type 16 mRNA-transcripts in cytological abnormal scrapings. J Med Virol (1992) 1.04
Prevalence of genital HPV infections in a regularly screened population in The Netherlands in relation to cervical cytology. J Med Virol (1988) 1.02
Infections of the cervix uteri with human papillomavirus and Chlamydia trachomatis. J Med Virol (1992) 1.02
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. Br J Cancer (2006) 1.01
Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol (1990) 1.00
Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol (2000) 1.00
Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol (1993) 1.00
Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study. Cancer (1999) 1.00
Rapid identification of thermotolerant Campylobacter jejuni, Campylobacter coli, Campylobacter lari, and Campylobacter upsaliensis from various geographic locations by a GTPase-based PCR-reverse hybridization assay. J Clin Microbiol (1999) 1.00
Detection and identification of Campylobacter spp. using the polymerase chain reaction. Cell Mol Biol (Noisy-le-grand) (1995) 0.98
PCR-mediated DNA typing of Campylobacter jejuni isolated from patients with recurrent infections. Res Microbiol (1994) 0.98
Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer (1996) 0.98
Bacterial vaginosis is not important in the etiology of cervical neoplasia: a survey on women with dyskaryotic smears. Sex Transm Dis (1996) 0.97